187 related articles for article (PubMed ID: 29099933)
41. Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73.
Goudsmit J; Renwick N; Dukers NH; Coutinho RA; Heisterkamp S; Bakker M; Schulz TF; Cornelissen M; Weverling GJ
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4838-43. PubMed ID: 10781089
[TBL] [Abstract][Full Text] [Related]
42. Higher prevalence of antibodies to human herpesvirus 8 in HIV-infected individuals than in the general population in Ghana, West Africa.
Nuvor SV; Katano H; Ampofo WK; Barnor JS; Sata T
Eur J Clin Microbiol Infect Dis; 2001 May; 20(5):362-4. PubMed ID: 11453603
[No Abstract] [Full Text] [Related]
43. Human herpesvirus 8 seroprevalence among internationally adopted children coming from Eastern Europe.
Viviano E; Vitale F; Perna AM; Cataldo F; Firenze A; Romano N
New Microbiol; 2009 Jan; 32(1):11-5. PubMed ID: 19382664
[TBL] [Abstract][Full Text] [Related]
44. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population.
Wagner HU; Van Dyck E; Roggen E; Nunn AJ; Kamali A; Schmid DS; Dobbins JG; Mulder DW
Int J STD AIDS; 1994; 5(5):332-7. PubMed ID: 7819350
[TBL] [Abstract][Full Text] [Related]
45. Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission.
de Sanjose S; Mbisa G; Perez-Alvarez S; Benavente Y; Sukvirach S; Hieu NT; Shin HR; Anh PT; Thomas J; Lazcano E; Matos E; Herrero R; Muñoz N; Molano M; Franceschi S; Whitby D
J Infect Dis; 2009 May; 199(10):1449-56. PubMed ID: 19351262
[TBL] [Abstract][Full Text] [Related]
46. Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda.
Nalwoga A; Nakibuule M; Marshall V; Miley W; Labo N; Cose S; Whitby D; Newton R
Clin Infect Dis; 2020 Aug; 71(4):1055-1062. PubMed ID: 31555829
[TBL] [Abstract][Full Text] [Related]
47. Kaposi Sarcoma-Associated Herpesvirus Infection and Endemic Burkitt Lymphoma.
Oluoch PO; Oduor CI; Forconi CS; Ong'echa JM; Münz C; Dittmer DP; Bailey JA; Moormann AM
J Infect Dis; 2020 Jun; 222(1):111-120. PubMed ID: 32072172
[TBL] [Abstract][Full Text] [Related]
48. Effects of Antiretroviral Therapy on Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Transmission Among HIV-Infected Zambian Children.
Olp LN; Minhas V; Gondwe C; Kankasa C; Wojcicki J; Mitchell C; West JT; Wood C
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26185193
[TBL] [Abstract][Full Text] [Related]
49. Kaposi's sarcoma-associated herpesvirus (KSHV) infection: endemic strains and cladograms from immunodeficient patients in China.
Zhu B; Chen Y; Xie Y; Wu N; Shendu J; Wang Y
J Clin Virol; 2008 May; 42(1):7-12. PubMed ID: 18164650
[TBL] [Abstract][Full Text] [Related]
50. Human herpesvirus 8 seroprevalence among children and adolescents in the United States.
Anderson LA; Li Y; Graubard BI; Whitby D; Mbisa G; Tan S; Goedert JJ; Engels EA
Pediatr Infect Dis J; 2008 Jul; 27(7):661-4. PubMed ID: 18536622
[TBL] [Abstract][Full Text] [Related]
51. Socio-economic and other correlates of Kaposi sarcoma-associated herpesvirus seroprevalence among older adults in Sicily.
Pelser C; Vitale F; Whitby D; Graubard BI; Messina A; Gafà L; Brown EE; Anderson LA; Romano N; Lauria C; Goedert JJ
J Med Virol; 2009 Nov; 81(11):1938-44. PubMed ID: 19777527
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of Kaposi's sarcoma associated herpesvirus among men attending sexually transmitted infections clinics in Anhui, China.
Wang J; Liu S; Cao Y; Yang L; Chen Y; Minhas V; Wood C; Zhang T
J Med Virol; 2016 Feb; 88(2):304-11. PubMed ID: 26147809
[TBL] [Abstract][Full Text] [Related]
53. Mother-to-child transmission of human herpesvirus-8 in South Africa.
Dedicoat M; Newton R; Alkharsah KR; Sheldon J; Szabados I; Ndlovu B; Page T; Casabonne D; Gilks CF; Cassol SA; Whitby D; Schulz TF
J Infect Dis; 2004 Sep; 190(6):1068-75. PubMed ID: 15319855
[TBL] [Abstract][Full Text] [Related]
54. Environmental determinants of Kaposi's sarcoma-associated herpesvirus (KSHV) transmission in rural Uganda (ENDKU study): Contributions to research on KSHV infection and reactivation in African children; A longitudinal cohort study.
Sabourin KR; Nalwoga A; Whitby D; Newton R; Rochford R
Cancer Epidemiol; 2022 Jun; 78():102154. PubMed ID: 35381467
[TBL] [Abstract][Full Text] [Related]
55. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
Lennette ET; Blackbourn DJ; Levy JA
Lancet; 1996 Sep; 348(9031):858-61. PubMed ID: 8826812
[TBL] [Abstract][Full Text] [Related]
56. Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy.
Calabrò ML; Sheldon J; Favero A; Simpson GR; Fiore JR; Gomes E; Angarano G; Chieco-Bianchi L; Schulz TF
J Hum Virol; 1998; 1(3):207-13. PubMed ID: 10195244
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.
Okroj M; Tedeschi R; Mancuso R; Brambilla L; Tourlaki A; Dillner J; Blom AM
Vaccine; 2011 Feb; 29(6):1129-34. PubMed ID: 21134448
[TBL] [Abstract][Full Text] [Related]
58. Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area.
Plancoulaine S; Abel L; Trégouët D; Duprez R; van Beveren M; Tortevoye P; Froment A; Gessain A
Cancer Res; 2004 Dec; 64(23):8782-7. PubMed ID: 15574792
[TBL] [Abstract][Full Text] [Related]
59. Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk.
Beachler DC; Gellert LL; Jacobson LP; Ambinder RF; Breen EC; Martínez-Maza O; Rabkin CS; Kaslow RA; D'Souza G
J Acquir Immune Defic Syndr; 2011 Feb; 56(2):188-92. PubMed ID: 21116187
[TBL] [Abstract][Full Text] [Related]
60. Serological and molecular evidence that human herpesvirus 8 is endemic among Amerindians in French Guiana.
Kazanji M; Dussart P; Duprez R; Tortevoye P; Pouliquen JF; Vandekerkhove J; Couppié P; Morvan J; Talarmin A; Gessain A
J Infect Dis; 2005 Nov; 192(9):1525-9. PubMed ID: 16206066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
